The overall objective of this project is to understand the molecular mechanisms by which insulin regulates glucose transport, specifically the translocation of GLUT4 glucose transporter proteins from a specialized intracellular membrane compartment to the cell surface membrane. Current data indicate that this specialized GLUT4-sequestration compartment exhibits a characteristic density upon velocity gradient centrifugation and is partially depleted upon insulin stimulation. Thus, this membrane organelle appears to be the direct target of insulin action relevant to GLUT4 translocation. This project will address two critically important questions: 1). What structural elements direct GLUT4 transporter proteins to the insulin-sensitive intracellular membrane compartment in insulin-target cells? 2). How does insulin receptor signaling regulate this specialized compartment, causing GLUT4 translocation? Question 1 will be addressed by expression in 3T3-L1 adipocytes of exofacial HA-tagged glucose transporter chimerase containing selective mutations of motifs in the GLUT4 COOH-terminal region that may operate independent of the dileucine motif in directing intracellular retention of GLUT4. Experiments designed to address question 2 will exploit new exciting data from this laboratory suggesting that insulin causes specific targeting of PI 3-kinase activity to the GLUT4 sequestration compartment. This hypothesis will be tested rigorously in both 3T3-L1 adipocytes and primary rat fat cells using velocity gradient centrifugation for isolation of GLUT4-enriched membranes. Novel PI3-kinases expressed in 3T3-L1 adipocytes will be identified by molecular cloning (one already in hand) to determine whether multiple PI 3-kinase enzymes may be involved in the GLUT4 trafficking pathway. Cellular localizations and insulin-sensitivity of such novel PI 3-kinases will be determined. The applicant will also test the hypothesis that specific proteins are recruited to or released from GLUT4-enriched membranes acutely in response to insulin (perhaps in response to localized 3' phosphoinositide generation) using high resolution two-dimensional gel electrophoresis. One such protein which is rapidly increased in content in GLUT4 vesicles by insulin has already been identified in this laboratory and is an exciting new candidate for regulating the movement of GLUT4 to the plasma membrane. The objective is to isolate cDNA clones of such insulin-regulated proteins in GLUT4-enriched vesicles as a first step in evaluating their functions sin the trafficking of these membranes.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
2R01DK030898-16
Application #
3569161
Study Section
Special Emphasis Panel (ZRG2-GMA-2 (01))
Project Start
1981-09-01
Project End
2001-08-31
Budget Start
1996-09-01
Budget End
1997-08-31
Support Year
16
Fiscal Year
1996
Total Cost
Indirect Cost
Name
University of Massachusetts Medical School Worcester
Department
Type
DUNS #
660735098
City
Worcester
State
MA
Country
United States
Zip Code
01655
Shen, Yuefei; Cohen, Jessica L; Nicoloro, Sarah M et al. (2018) CRISPR-delivery particles targeting nuclear receptor-interacting protein 1 (Nrip1) in adipose cells to enhance energy expenditure. J Biol Chem 293:17291-17305
Guilherme, Adilson; Pedersen, David J; Henriques, Felipe et al. (2018) Neuronal modulation of brown adipose activity through perturbation of white adipocyte lipogenesis. Mol Metab 16:116-125
Czech, Michael P (2017) Insulin action and resistance in obesity and type 2 diabetes. Nat Med 23:804-814
Guilherme, Adilson; Pedersen, David J; Henchey, Elizabeth et al. (2017) Adipocyte lipid synthesis coupled to neuronal control of thermogenic programming. Mol Metab 6:781-796
Fitzgibbons, Timothy P; Czech, Michael P (2016) Emerging evidence for beneficial macrophage functions in atherosclerosis and obesity-induced insulin resistance. J Mol Med (Berl) 94:267-75
Roth Flach, Rachel J; Danai, Laura V; DiStefano, Marina T et al. (2016) Protein Kinase Mitogen-activated Protein Kinase Kinase Kinase Kinase 4 (MAP4K4) Promotes Obesity-induced Hyperinsulinemia. J Biol Chem 291:16221-30
Cohen, Jessica L; Shen, Yuefei; Aouadi, Myriam et al. (2016) Peptide- and Amine-Modified Glucan Particles for the Delivery of Therapeutic siRNA. Mol Pharm 13:964-978
Roth Flach, Rachel J; Guo, Chang-An; Danai, Laura V et al. (2016) Endothelial Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 Is Critical for Lymphatic Vascular Development and Function. Mol Cell Biol 36:1740-9
(2015) 22nd European Congress on Obesity (ECO2015), Prague, Czech Republic, May 6-9, 2015: Abstracts. Obes Facts 8 Suppl 1:1-272
Roth Flach, Rachel J; Czech, Michael P (2015) NETs and traps delay wound healing in diabetes. Trends Endocrinol Metab 26:451-2

Showing the most recent 10 out of 77 publications